The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Open accessAbstract
Glioblastoma (GBM) is a highly lethal brain tumour presenting as one of two subtypes with distinct clinical histories and molecular profiles. The primary GBM subtype presents acutely as a high-grade disease that typically harbours mutations in EGFR, PTEN and INK4A/ARF (also known as CDKN2A), and the secondary GBM subtype evolves from the slow progression of a low-grade disease that classically possesses PDGF and TP53 events. Here we show that concomitant central nervous system (CNS)-specific deletion of p53 and Pten in the mouse CNS generates a penetrant acute-onset high-grade malignant glioma phenotype with notable clinical, pathological and molecular resemblance to primary GBM in humans. This genetic observation prompted TP53 and PTEN mutational analysis in human primary GBM, demonstrating unexpectedly frequent inactivating mutations of TP53 as well as the expected PTEN mutations. Integrated transcriptomic profiling, in silico promoter analysis and functional studies of murine neural stem cells (NSCs) established that dual, but not singular, inactivation of p53 and Pten promotes an undifferentiated state with high renewal potential and drives increased Myc protein levels and its associated signature. Functional studies validated increased Myc activity as a potent contributor to the impaired differentiation and enhanced renewal of NSCs doubly null for p53 and Pten (p53(-/-) Pten(-/-)) as well as tumour neurospheres (TNSs) derived from this model. Myc also serves to maintain robust tumorigenic potential of p53(-/-) Pten(-/-) TNSs. These murine modelling studies, together with confirmatory transcriptomic/promoter studies in human primary GBM, validate a pathogenetic role of a common tumour suppressor mutation profile in human primary GBM and establish Myc as an important target for cooperative actions of p53 and Pten in the regulation of normal and malignant stem/progenitor cell differentiation, self-renewal and tumorigenic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although TP53 mutations are oncogenic in GBM, other genes, such as PTEN must also be mutated to drive GBM progression [28].”
From The p53 Pathway in Glioblastoma (2018) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Similarly, the chronic cellular damage that leads to liver cirrhosis results in shortened telomeres, anaphase bridges and a dramatically increased risk of liver cancer (131-134).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,675
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Self-citationErratum to: The 2007 WHO classification of tumours of the central nervous system
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-156115 · Cited by 4,435
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133
Self-citationClarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C., Jamieson, C., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,124
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
Self-citationMultiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityPreprint
Sears, R. C., Nuckolls, F., Haura, E. B., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,411
Cited by
Sorted by citations
Items 301–400 of 759
Hwang, I., Cao, D., Na, Y., Kim, D.-Y., Zhang, T., Yao, J., Oh, H., HU, J. L., Zheng, H., Yao, Y., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.02.013 · Cited by 38
Self-citationRole and mechanism of neural stem cells of the subventricular zone in glioblastoma
Zhang, G., Wang, C., Qian, C., Ji, Y., & Wang, Y. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i7.877 · Cited by 39
Self-citationNovel Perspectives on p53 Function in Neural Stem Cells and Brain Tumors
Hede, S., Nazarenko, I., Nistér, M., & Lindström, M. S. (2010) · Journal of Oncology · doi:10.1155/2011/852970 · Cited by 40
Pei, J., Park, I.-H., Ryu, H., Li, S.-Y., Li, C., Lim, S.-H., Wen, M., Jang, W., & Jung, S. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0475-8 · Cited by 37
Karsy, M. J., Guan, J., Jensen, R. L., Huang, E. L., & Colman, H. (2015) · World Neurosurgery · doi:10.1016/j.wneu.2015.12.032 · Cited by 40
A reignited debate over the cell(s) of origin for glioblastoma and its clinical implications
Fan, X., Xiong, Y., & Wang, Y. (2019) · Frontiers of Medicine · doi:10.1007/s11684-019-0700-1 · Cited by 37
Self-citationThe Subventricular Zone in Glioblastoma: Genesis, Maintenance, and Modeling
Beiriger, J., Habib, A., Jovanovich, N., Kodavali, C. V., Edwards, L., Amankulor, N., & Zinn, P. O. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.790976 · Cited by 38
The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy
Wang, G., Wang, J., Zhao, H., Wang, J., & To, S. S. T. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.07.005 · Cited by 38
Glioblastoma Multiforme Stem Cells
Dimov, I., Tasic-Dimov, D., Conić, I., & Stefanović, V. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.42 · Cited by 38
p53-dependent pathways in neurite outgrowth and axonal regeneration
Giovanni, S. D., & Rathore, K. I. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1292-5 · Cited by 37
Lopez, X. M., Debeir, O., Maris, C., Rorive, S., Roland, I. H., Saerens, M., Salmon, I. J., & Decaestecker, C. (2012) · Cytometry Part A · doi:10.1002/cyto.a.22085 · Cited by 36
Schmid, R. S., Simon, J. M., Vitucci, M., McNeill, R. S., Bash, R., Werneke, A. M., Huey, L., White, K., Ewend, M. G., Wu, J., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov321 · Cited by 36
Marampon, F., Leoni, F., Mancini, A., Pietrantoni, I., Codenotti, S., Letizia, F., Megiorni, F., Porro, G., Galbiati, E., Pozzi, P., et al. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2800-8 · Cited by 36
p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation
Panicker, S. P., Raychaudhuri, B., Sharma, P., Tipps, R. S., Mazumdar, T., Mal, A. K., Palomo, J. M., Vogelbaum, M. A., & Haque, S. J. (2010) · Oncotarget · doi:10.18632/oncotarget.139 · Cited by 36
Jiang, X. J., Dong, X., Li, S., Zhou, Y., Rayner, S., Xia, H., Gao, G. F., Yuan, H., Tang, Y., & Luo, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01067 · Cited by 35
Neuroligin 3 Regulates Dendritic Outgrowth by Modulating Akt/mTOR Signaling
Xu, J., Du, Y.-L., Xu, J.-W., Hu, X., Gu, L.-F., Li, X., Hu, P.-H., Liao, T., Xia, Q.-Q., Sun, Q., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00518 · Cited by 35
Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities
Haase, S., Núñez, F. M., Gauss, J. C., Thompson, S., Brumley, E. K., Lowenstein, P. R., & Castro, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249654 · Cited by 35
Kim, H. S., Woolard, K., Lai, C., Bauer, P. O., Maric, D., Song, H., Li, A., Kotliarova, S. E., Zhang, W., & Fine, H. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2594 · Cited by 36
Modeling microRNA-Transcription Factor Networks in Cancer
Aguda, B. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-5590-1_9 · Cited by 34
Seeing is Believing: Are Cancer Stem Cells the Loch Ness Monster of Tumor Biology?
Lathia, J. D., Venere, M., Rao, M. S., & Rich, J. N. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9194-6 · Cited by 34
S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53
Yang, T., Cheng, J., Yang, Y., Qi, W., Zhao, Y., Long, H., Xie, R., & Zhu, B. (2016) · Stem Cells · doi:10.1002/stem.2472 · Cited by 34
Expression of miR-145 and Its Target Proteins Are Regulated by miR-29b in Differentiated Neurons
Jauhari, A., Singh, T., & Yadav, S. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1009-9 · Cited by 24
Zhang, D., Liu, C., Li, H., & Jiao, J. (2020) · Advanced Science · doi:10.1002/advs.202002117 · Cited by 35
Cancer Association Study of Aminoacyl-tRNA Synthetase Signaling Network in Glioblastoma
Kim, Y., Kwon, C., Liu, J.-L., Kim, S. H., & Kim, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040960 · Cited by 34
Epigenetic setting and reprogramming for neural cell fate determination and differentiation
Imamura, T., Uesaka, M., & Nakashima, K. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0511 · Cited by 33
Wu, J., Jiang, Y., Cao, W., Li, X., Xie, C., Geng, S., Zhu, M., Liang, Z., Zhu, J., Zhu, W., et al. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.05.040 · Cited by 33
p53 balances between tissue hierarchy and anarchy
Koifman, G., Aloni-Grinstein, R., & Rotter, V. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz022 · Cited by 33
Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis
Yuan, J., Peng, G., Xiao, G., Yang, Z., Huang, J., Liu, Q., Yang, Z., & Liu, D. (2020) · Journal of Cancer · doi:10.7150/jca.33045 · Cited by 33
The Evolution of Tumor Microenvironment in Gliomas and Its Implication for Target Therapy
Hu, Y., Li, Z., Zhang, Y., Wu, Y. C., Liu, Z., Zeng, J., Hao, Z., Li, J., Ren, J., & Yao, M. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.83531 · Cited by 37
Will Kinase Inhibitors Make it as Glioblastoma Drugs?
Mellinghoff, I. K., Schultz, N. D., Mischel, P. S., & Cloughesy, T. F. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_178 · Cited by 36
Nanog, Gli, and p53: a new network of stemness in development and cancer
Brandner, S. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.162 · Cited by 33
Faithfull Modeling of PTEN Loss Driven Diseases in the Mouse
Nardella, C., Carracedo, A., Salmena, L., & Pandolfi, P. P. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_62 · Cited by 34
Balasubramaniyan, V., Vaillant, B. D., Wang, S., Gumin, J., Butalid, M. E., Sai, K., Mukheef, F., Kim, S. H., Boddeke, H. W. G. M., Lang, F. F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5219 · Cited by 32
Wang, Q., Jia, S., Wang, D., Chen, X., Kalvakolanu, D. V., Zheng, H., Wei, X., Wen, N., Liang, H., Guo, B., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0037 · Cited by 32
Self-citationGenetic Abnormalities, Clonal Evolution, and Cancer Stem Cells of Brain Tumors
Testa, U., Castelli, G., & Pelosi, E. (2018) · Medical Sciences · doi:10.3390/medsci6040085 · Cited by 33
Maire, C. L., Ramkissoon, S. H., Hayashi, M., Haidar, S., Ramkissoon, L. A., DiTomaso, E., & Ligon, K. L. (2013) · Stem Cells · doi:10.1002/stem.1590 · Cited by 30
Self-citationFirat, E., & Niedermann, G. (2016) · Oncotarget · doi:10.18632/oncotarget.10702 · Cited by 30
Jauhari, A., Singh, T., Pandey, A., Singh, P., Singh, N., Srivastava, A. K., Pant, A. B., Parmar, D., & Yadav, S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0042-9 · Cited by 30
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells
Daniele, S., Pietrobono, D., Costa, B., Giustiniano, M., Pietra, V. L., Giacomelli, C., Regina, G. L., Silvestri, R., Taliani, S., Trincavelli, M. L., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00023 · Cited by 31
p53 and its mutants on the slippery road from stemness to carcinogenesis
Molchadsky, A., & Rotter, V. (2017) · Carcinogenesis · doi:10.1093/carcin/bgw092 · Cited by 30
Hao, M., Chen, L., He, J., Zhao, X., Xia, H., Chen, X., Yu, L., Qiu, J., Feng, S., Sang, Y., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202214869 · Cited by 29
Dual Pten/Tp53 Suppression Promotes Sarcoma Progression by Activating Notch Signaling
Guijarro, M. V., Dahiya, S. M., Danielson, L. S., Segura, M. F., Vales-Lara, F. M., Menéndez, S., Popiolek, D. A., Mittal, K., Wei, J., Zavadil, J., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.035 · Cited by 29
HBEGF promotes gliomagenesis in the context of Ink4a/Arf and Pten loss
Shin, C., Robinson, J. P., Sonnen, J. A., Welker, A., Yu, D., VanBrocklin, M. W., & Holmen, S. L. (2017) · Oncogene · doi:10.1038/onc.2017.83 · Cited by 29
Li, N., Zhang, Y., Šidlauskas, K., Ellis, M. J., Evans, I. M., Frankel, P., Lau, J., El-Hassan, T., Guglielmi, L., Broni, J., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0277-1 · Cited by 30
The necessity for standardization of glioma stem cell culture: a systematic review
Zhang, L., Yu, H., Yuan, Y., Yu, J. S., Lou, Z., Xue, Y., & Liu, Y. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01589-8 · Cited by 29
The potential origin of glioblastoma initiating cells
David, A. C. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/261 · Cited by 29
Genome-wide analysis of DNA methylation in UVB- and DMBA/TPA-induced mouse skin cancer models
Yang, Y., Lee, J. H., Shu, L., Zhang, C., Su, Z., Lu, Y.-P., Huang, M., Ramirez, C. N., Pung, D., Huang, Y. S., et al. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.07.031 · Cited by 29
NKX2.2 Suppresses Self-Renewal of Glioma-Initiating Cells
Muraguchi, T., Tanaka, S., Yamada, D., Tamase, A., Nakada, M., Nakamura, H., Hoshii, T., Ooshio, T., Tadokoro, Y., Naka, K., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2304 · Cited by 30
Glioblastoma Stem Cells: A Neuropathologist's View
McLendon, R. E., & Rich, J. N. (2010) · Journal of Oncology · doi:10.1155/2011/397195 · Cited by 29
Gatekeeper Between Quiescence and Differentiation
Quadrato, G., & Giovanni, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-398309-1.00005-6 · Cited by 28
Riddick, G., Kotliarova, S. E., Rodriguez, V., Kim, H., Linkous, A. G., Storaska, A. J., Ahn, S. J., Walling, J., Belova, G. I., & Fine, H. A. (2017) · Scientific Reports · doi:10.1038/srep43605 · Cited by 28
Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment
Fu, Z., Zhu, G., Luo, C., Chen, Z., Dou, Z., Chen, Y., Chen, Z., Su, S., & Liu, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.971462 · Cited by 29
Immunological considerations of modern animal models of malignant primary brain tumors
Sughrue, M. E., Yang, I., Kane, A. J., Rutkowski, M. J., Fang, S., James, C. D., & Parsa, A. T. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-84 · Cited by 28
Şengelen, A., & Uçar, E. Ö. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156060 · Cited by 27
HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells
Zhong, X., Liu, X., Li, Y., Cheng, M., Wang, W., Tian, K., Mu, L., Zeng, T., Liu, Y., Jiang, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9744 · Cited by 27
Ramaiah, M. J., Ramalingam, P. S., Mathavan, S., Yamajala, R. B. R. D., Moparthi, N. R., Kurappalli, R. K., & Manyam, R. R. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109876 · Cited by 27
Pre-clinical models for evaluating glioma targeted immunotherapies
Frederico, S. C., Zhang, X., Hu, B., & Kohanbash, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1092399 · Cited by 27
García‐Montaño, L. A., Licón-Muñoz, Y., Martinez, F. J., Keddari, Y. R., Ziemke, M. K., Chohan, M. O., & Piccirillo, S. G. M. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0048 · Cited by 27
The dosage of Patz1 modulates reprogramming process
Ma, H., Ow, J. R., Tan, B. C. P., Goh, Z., Feng, B., Loh, Y., Fedele, M., Li, H., & Wu, Q. (2014) · Scientific Reports · doi:10.1038/srep07519 · Cited by 27
From Birth Till Death: Neurogenesis, Cell Cycle, and Neurodegeneration
Demir, O., Singh, S. K., Klimaschewski, L. P., & Kurnaz, I. A. (2009) · The Anatomical Record · doi:10.1002/ar.20980 · Cited by 27
Sun, C., Chuang, H., Wang, J., Chen, S.-S., Cheng, Y., Lee, C.-F., & Chern, Y. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20802 · Cited by 27
DAI, B., Wan, W., Zhang, P., Yisong, Z., Pan, C., Meng, G., Xiao, X., Wu, Z., Jia, W., Zhang, J., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4239 · Cited by 29
RetractedFOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration
Frattini, V., Pisati, F., Speranza, M. C., Poliani, P. L., Frigè, G., Cantini, G., Kapetis, D., Cominelli, M., Rossi, A., Finocchiaro, G., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.644 · Cited by 27
Divergent Roles of PI3K Isoforms in PTEN-Deficient Glioblastomas
Xie, S.-Z., Ni, J., McFaline-Figueroa, J., Wang, Y., Bronson, R., Ligon, K., Wen, P., Roberts, T., & Zhao, J. J. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108196 · Cited by 24
Self-citationThe adaptive significance of adult neurogenesis: an integrative approach
Konefal, S., Elliot, M., & Crespi, B. J. (2013) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2013.00021 · Cited by 29
QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway
Han, B. R., Wang, R., Chen, Y., Meng, X., Wu, P., Li, Z., Duan, C., Li, Q., Li, Y., Zhao, S., et al. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00463-x · Cited by 26
To Become or Not to Become Tumorigenic: Subventricular Zone Versus Hippocampal Neural Stem Cells
Fontán‐Lozano, Á., Morcuende, S., de Carrizosa, M. A. D., Benítez‐Temiño, B., Mejı́as, R., & Matarredona, E. R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.602217 · Cited by 28
Luca, C. D., Virtuoso, A., Papa, M., Certo, F., Barbagallo, G. M. V., & Altieri, R. (2022) · Cells · doi:10.3390/cells11081349 · Cited by 27
RSL3 triggers glioma stem cell differentiation via the Tgm2/AKT/ID1 signaling axis
Li, M., Song, D. E., Chen, X., Wang, X., Xu, L., Yang, M., Yang, J., Kalvakolanu, D. V., Wei, X., Liu, X., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166529 · Cited by 26
Epigenetic Regulation of Survivin by Bmi1 Is Cell Type Specific During Corticogenesis and in Gliomas
Acquati, S., Greco, A., Licastro, D., Bhagat, H., Ceric, D., Rossini, Z., Grieve, J., Shaked-Rabi, M., Henriquez, N. V., Brandner, S., et al. (2012) · Stem Cells · doi:10.1002/stem.1274 · Cited by 27
Lin, Y., Murayama, Y., Hashimoto, K., Nakamura, Y., Lin, C.-S., Yokoyama, K. K., & Saito, S. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt447 · Cited by 27
microRNA-200a silencing protects neural stem cells against cerebral ischemia/reperfusion injury
Ma, J., Shui, S., Han, X., Guo, D., Li, T., & Lei, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172178 · Cited by 26
Guan, C., Luan, L., Li, J., & Yang, L. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147576 · Cited by 26
A comprehensive overview on the molecular biology of human glioma: what the clinician needs to know
López, P. D. D., Saiz-López, P., Gargini, R., Sola-Vendrell, E., & Tejada, S. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02340-8 · Cited by 26
Wu, M., Chen, Y., Chen, H.-H., Chang, K.-W., Chang, I.-S., Wang, L., & Hsu, H. L. (2014) · Oncogene · doi:10.1038/onc.2014.125 · Cited by 25
Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma
Yamaki, T., Suenaga, Y., Iuchi, T., Alagu, J., Takatori, A., Itami, M., Araki, A., Ohira, M., Inoue, M., Kageyama, H., et al. (2013) · Scientific Reports · doi:10.1038/srep01160 · Cited by 25
Olar, A., Raghunathan, A., Albarracin, C. T., Aldape, K., Cahill, D. P., Powell, S. Z.-E., Goodman, J. C., & Fuller, G. N. (2011) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2011.08.010 · Cited by 25
Generation of Induced Pluripotent Stem Cells from Somatic Cells
Sohn, Y.-D., Han, J. W., & Yoon, Y. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-398459-3.00001-0 · Cited by 25
Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme
Yu, Q., Takahashi, M., Sheets, K. G., Soto, H., Tsui, J. L., Pelargos, P. E., Antonios, J. P., Kasahara, N., Yang, I., Prins, R. M., et al. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2507-8 · Cited by 25
Foxr2 promotes formation of CNS-embryonal tumors in a Trp53-deficient background
Poh, B. M., Koso, H., Momota, H., Komori, T., Suzuki, Y., Yoshida, N., Ino, Y., Todo, T., & Watanabe, S. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz067 · Cited by 26
Genetic changes in the PTEN gene and their association with breast cancer in Pakistan.
Baig, R. M., Mahjabeen, I., Sabir, M., Masood, N., Hafeez, S., Malik, F. A., & Kayani, M. A. (2011) · PubMed · Cited by 25
Long, P. M., Tighe, S. W., Driscoll, H. E., Moffett, J. R., Namboodiri, A. M. A., Viapiano, M. S., Lawler, S. E., & Jaworski, D. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080714 · Cited by 25
CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle
Zhou, H.-Y., Wang, Y., Wang, T., Wu, W., Cao, Y., Zhang, B.-C., Wang, M., & Mao, P. (2024) · Oncology Letters · doi:10.3892/ol.2024.14339 · Cited by 25
Self-citationDiME: A Scalable Disease Module Identification Algorithm with Application to Glioma Progression
Liu, Y., Tennant, D. A., Zhu, Z., Heath, J. K., Yao, X., & He, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086693 · Cited by 24
Kaus, A., Widera, D., Kassmer, S. H., Peter, J. O., Zaenker, K. S., Kaltschmidt, C., & Kaltschmidt, B. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0416 · Cited by 24
Yamada, K., Tso, J. L., Ye, F., Choe, J., Liu, Y., Liau, L. M., & Tso, C.-L. (2011) · Cancers · doi:10.3390/cancers3021975 · Cited by 24
Kwon, S.-J., Kwon, O., Kim, K.-T., Go, Y.-H., Yu, S.-I., Lee, B., Miyoshi, H., Oh, E., Cho, S.-J., & Cha, H. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0703-y · Cited by 24
Upregulation of KIF11 in TP53 Mutant Glioma Promotes Tumor Stemness and Drug Resistance
Liu, B., Zhang, G., Cui, S., & Du, G. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-01038-3 · Cited by 24
Xu, L., Zhang, L., Zhang, S., Yang, J., Zhu, A., Sun, J., Kalvakolanu, D. V., Cong, X., Zhang, J., Tang, J., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155199 · Cited by 24
Bidirectional Relation Between Parkinson's Disease and Glioblastoma Multiforme
Mencke, P., Hanss, Z., Boussaad, I., Sugier, P., Elbaz, A., & Krüger, R. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00898 · Cited by 25
Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma?
Wu, C. L., Yang, P., Liu, B., & Tang, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s232464 · Cited by 29
Verma, R., Chen, X., Xin, D. E., Luo, Z., Ogurek, S., Xin, M., Rao, R., Berry, K., & Lu, Q. R. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-1577 · Cited by 23
Insights gained from modelling high‐grade glioma in the mouse
Rankin, S. L., Zhu, G., & Baker, S. J. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01231.x · Cited by 23
In Vivo Modeling of Malignant Glioma
Kegelman, T. P., Hu, B., Emdad, L., Das, S. K., Sarkar, D., & Fisher, P. B. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800249-0.00007-x · Cited by 23
Molecular, histopathological, and genomic variants of glioblastoma
Karsy, M. J. (2014) · Frontiers in bioscience · doi:10.2741/4268 · Cited by 23
Cancer Stem Cells and the Biology of Brain Tumors
Flores, D. G., Ledur, P. F., Abujamra, A. L., Brunetto, A. L., Schwartsmann, G., Lenz, G., & Roesler, R. (2009) · Current Stem Cell Research & Therapy · doi:10.2174/157488809789649214 · Cited by 23
Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells
Wang, Y., Gao, S., Wang, W., & Liang, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5964 · Cited by 23
Self-citationКоbylinska, L. I., Klyuchivska, O., Grytsyna, I. I., Finiuk, N. S., Panchuk, R. R., Starykovych, M. O., Lehka, L., Lesyk, R., Zimenkovsky, B. S., & Stoika, R. S. (2017) · Croatian Medical Journal · doi:10.3325/cmj.2017.58.150 · Cited by 23
Karimzadeh, S., Hosseinkhani, S., Fathi, A., Ataei, F., & Baharvand, H. (2018) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2018.01.005 · Cited by 22
Nangare, S., Chandankar, S., & Patil, P. O. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105060 · Cited by 22
Metadata
- Authors
- Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., Stommel, J. M., Dunn, K. L., Wiedemeyer, R., You, M. J., Brennan, C., Wang, Y. A., Ligon, K. L., Wong, W. H., Chin, L., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Stanford University (US)
- Memorial Sloan Kettering Cancer Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- DePinho, Ronald A.
- ORCID
- Venue
- Nature
- Published
- 2008-10
- Volume
- 455
- Issue
- 7216
- Pages
- 1129-1133
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4051433
- OpenAlex
- W2109610561
- Cited by
- 767
- References
- 37
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 32 · 2023: 41 · 2022: 33 · 2021: 32 · 2020: 41 · 2019: 33 · 2018: 35 · 2017: 38 · 2016: 39 · 2015: 46 · 2014: 47 · 2013: 61 · 2012: 76
- FWCI
- 27.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- National Cancer Institute (R01 CA99041, R01CA099041, U01CA84313, 5P01CA95616, U01CA084313, P01CA095616)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- p53, PTEN, glioblastoma, neural stem cells, glioma stem cells, c-Myc, tumor suppressor inactivation, cell differentiation, cell renewal, TP53 mutation, PTEN mutation, gene expression profiling, promoter analysis, EGFR, neurofibromatosis type 1, RB1, ATM, APC
- MeSH terms
- Animals, Brain Neoplasms, Cell Differentiation, Gene Expression Regulation, Glioblastoma, Glioma, Humans, Immunohistochemistry, Neurons, Neoplastic Stem Cells, Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-myc, Cell Proliferation, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review